Literature DB >> 10992570

Surgical treatment of nasal polyposis in patients with aspirin intolerance.

W Hosemann1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992570      PMCID: PMC1765953          DOI: 10.1136/thorax.55.suppl_2.s87

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  33 in total

1.  Evaluation of prognostic factors in endoscopic sinus surgery.

Authors:  S C Marks; F Shamsa
Journal:  Am J Rhinol       Date:  1997 May-Jun

2.  Long-term results of functional endoscopic sinus surgery.

Authors:  B A Senior; D W Kennedy; J Tanabodee; H Kroger; M Hassab; D Lanza
Journal:  Laryngoscope       Date:  1998-02       Impact factor: 3.325

Review 3.  Epidemiology and prevalence of aspecific chronic sinusitis.

Authors:  F Gordts; P A Clement
Journal:  Acta Otorhinolaryngol Belg       Date:  1997

4.  Comparison of functional results after ethmoidectomy and nasalization for diffuse and severe nasal polyposis.

Authors:  R Jankowski; D Pigret; F Decroocq
Journal:  Acta Otolaryngol       Date:  1997-07       Impact factor: 1.494

5.  The clinical relationship of nasal polyps to asthma.

Authors:  K Larsen
Journal:  Allergy Asthma Proc       Date:  1996 Sep-Oct       Impact factor: 2.587

6.  Surgical treatment of aspirin triad sinusitis.

Authors:  E A McFadden; B T Woodson; J N Fink; R J Toohill
Journal:  Am J Rhinol       Date:  1997 Jul-Aug

7.  Powered instrumentation in functional endoscopic sinus surgery. I: Surgical technique.

Authors:  D A Christmas; J H Krouse
Journal:  Ear Nose Throat J       Date:  1996-01       Impact factor: 1.697

8.  Ketorlac-induced status asthmaticus after endoscopic sinus surgery in a patient with Samter's triad.

Authors:  M A Dias; J F Biedlingmaier
Journal:  Otolaryngol Head Neck Surg       Date:  1997-12       Impact factor: 5.591

9.  Orbital complications of sinusitis in the aspirin triad syndrome.

Authors:  E A McFadden; B T Woodson; B M Massaro; R J Toohill
Journal:  Laryngoscope       Date:  1996-09       Impact factor: 3.325

10.  100 years of frontal sinus surgery.

Authors:  J B Jacobs
Journal:  Laryngoscope       Date:  1997-11       Impact factor: 3.325

View more
  8 in total

1.  Clinical outcome of partial ethmoidectomy for chronic rhinosinusitis.

Authors:  Heinrich Iro; Susanne Mayr; Bernhard Schick; Gracia Mrakovcic; Malte Erik Wigand
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-02-22       Impact factor: 2.503

Review 2.  Aspirin-sensitive asthma and upper airway diseases.

Authors:  Jinny E Chang; William Chin; Ronald Simon
Journal:  Am J Rhinol Allergy       Date:  2012 Jan-Feb       Impact factor: 2.467

3.  [Aspirin desensitization: therapy options in patients with aspirin-exacerbated respiratory disease].

Authors:  R Weber; A Trautmann; W Randerath; W Heppt; W Hosemann
Journal:  HNO       Date:  2012-04       Impact factor: 1.284

4.  Appraisal of the Real-World Effectiveness of Biologic Therapies in Aspirin-Exacerbated Respiratory Disease.

Authors:  Hannah Wangberg; Samantha R Spierling Bagsic; Lilliana Osuna; Andrew A White
Journal:  J Allergy Clin Immunol Pract       Date:  2021-09-28

5.  Aspirin-exacerbated asthma.

Authors:  Mathew Varghese; Richard F Lockey
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

Review 6.  Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

Authors:  Tanya M Laidlaw; Joshua A Boyce
Journal:  Immunol Allergy Clin North Am       Date:  2012-12-23       Impact factor: 3.479

7.  Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease.

Authors:  Rachel Howe; Rita M Mirakian; Prathap Pillai; Simon Gane; Yvonne C Darby; Glenis K Scadding
Journal:  World Allergy Organ J       Date:  2014-07-29       Impact factor: 4.084

Review 8.  Samter's Triad: State of the Art.

Authors:  Sung-Dong Kim; Kyu-Sup Cho
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-04-13       Impact factor: 3.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.